Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes
NCT07282613 · NOT YET RECRUITING · Phase 3
We track 6 ClinicalTrials.gov studies led by Novo Nordisk As. The portfolio skews toward Phase 3 (5 trials).
6 clinical trials sponsored by Novo Nordisk As.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 5 | 83% |
| Phase 1 | 1 | 17% |
Novo Nordisk As currently sponsors 6 clinical trials tracked on ReadTheTrial. These span Phase 3, Phase 1.
Novo Nordisk As conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Novo Nordisk As currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.